🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06433817
Recruiting Observational

Spectral CT in Radiotherapy for Cervical Cancer

NCT06433817 · tracked via the Priya Life Science China tracker
Sponsor
Peking Union Medical College Hospital
Phase
Observational
Started
2024-05-22
Last updated
2024-05-30

Condition(s) studied

Cervical CancerRadiotherapy

Investigational drug(s) / intervention(s)

Spectral computed tomography scan

Spectral computed tomography scan: Spectral CT scans acquisition performed during the arterial phase and venous phase for cervical cancer

Study summary

The purpose of this study was to explore the potential application of spectral CT for radiotherapy in cervical cancer.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. All patients were confirmed cervical cancer by pathology 2. patients were treated with concurrent chemoradiotherapy 3. Spectral CT scans acquisition performed during the arterial phase and venous phase 4. All the patients underwent a 18F-FDG PET/CT before treatment Exclusion Criteria: 1. CT without spectral scans 2. History of allergy to intravenous contrast 3. Pregnant or potentially pregnant female subjects

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Peking Union Medical College Hospital Beijing Beijing Municipality Recruiting

More Peking Union Medical College Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06433817 on ClinicalTrials.gov ↗ ← All trials in China